腎機能検査の市場規模、シェア、動向分析レポート：製品別（クリアランス検査、尿検査、血液検査、希釈・濃縮検査、その他検査）、最終用途別、地域別、セグメント別予測、2023年～2030年

腎機能検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の腎機能検査の市場規模は、2023年から2030年にかけて6.50%のCAGRで登録され、2030年までに13億9000万米ドルに達すると予測されています。腎臓疾患の高い有病率、研究開発活動の高まり、市場関係者による投資の増加、技術革新などの主要な要因が、市場成長を著しく促進すると予測されます。さらに、診断検査に対する償還など、さまざまな施設を提供するための政府による取り組みが増加していることも、市場を押し上げる主な要因となっています。

事業者により革新的な腎機能検査が市場に導入されることで、これらの診断検査の採用が増加しています。例えば、2022年12月、ジャーニー・バイオサイエンス社は、主力製品-NaviDKDを発売しました。これはバイオマーカーに基づく血液検査で、症状が現れる何年も前に、糖尿病患者の腎疾患の危険性を評価するものです。本製品は、特許取得済みのレポートプラットフォーム「compass」とともに、合併症を未然に管理・予防するための実用的な知見を提供します。このような新興国市場の開拓は、予測期間中に市場を活性化させるものと期待されています。

さらに、新規製品開発のための研究開発イニシアティブの高まりは、予測期間中の市場成長を著しく促進すると予想されます。例えば、2021年2月、University Hospitals of Derby and Burton, NHS Foundation Trust, and the University of Nottinghamの研究者は、腎疾患の治療と診断を改善するための資金として232万米ドルを受け取りました。研究者たちは、マルチパラメトリックMRIスキャンを使用して、CKDに苦しむ患者を評価する予定です。同様に、カナダの腎臓研究機関は、2027年までの活動を支援するため、新たに1,180万米ドルの出資を受けました。Can-SOLVE慢性腎臓病ネットワークは、カナダで過去最大規模の腎臓研究イニシアチブです。

COVID-19の大流行により、国内では入院や感染症のホットスポットが増加しました。2021年6月までに世界中で少なくとも3回のCOVID-19の波があり、病院のリソース、特に労働力や透析機器・用品の確保に大きな負担がかかっています。さらに、COVID-19の大流行は、腎臓病患者に対するヘルスケアサービスにも影響を及ぼしました。世界的に社会的疎外と閉鎖が義務化され、他の医療サービスの一時的な閉鎖につながりました。パンデミックの期間中、緊急ではない診察や検査サービスが停止したため、いくつかの腎臓疾患の診断が延期されました。

さらに、腎臓疾患の有病率の増加は、研究期間中に診断テストの需要を増加させると予測されています。例えば、The National Kidney Foundation, Inc.によると、米国では推定3700万人、すなわち成人の7人に1人以上が何らかの腎臓疾患を抱えて生活しています。同様に、FDAが発表したデータによると、米国では毎年約1万人の子どもが急性腎臓感染症（AKI）を発症しています。これらの子どもたちの生存率は約38%～43%です。また、新生児のAKIによる死亡率は約60%です。このような要因が新生児血液透析の需要を高め、市場の成長を促すと考えられます。

一方、腎臓疾患に関する認知度の低さは、市場成長の妨げになると予想されます。例えば、米国では約3,700万人の成人が腎臓病を患っていると推定されていますが、約90%がこの病気について知らないままになっています。腎臓病の主な危険因子は、高血圧や糖尿病、心臓病、肥満、腎臓病の家族歴などです。しかし、様々な政府機関が腎機能検査に対する意識を高めるためのプログラムを開始しています。例えば、Tamilnadu Kidney Research Foundationは、2020年3月までに1,279の啓発プログラムを実施しました。

腎機能検査市場レポートハイライト

製品別では、クリアランス検査部門が最大のシェアを占めています。これらの検査は、最適な感度と精度により、性能のばらつきを最小限に抑えることができます。低コストで入手しやすいことから、導入が進んでいます。

最終用途別では、CKDの有病率の増加によりIVD検査の需要が高まっていることから、2022年の市場シェアは病院セグメントが圧倒的に高いです。

北米は、確立されたヘルスケアインフラ、有利な償還政策、政府の取り組みにより、2022年の世界市場を独占しています。

アジア太平洋地域は、中国やインドなどの新興国におけるCKDに関する認識プログラムの増加により、将来的に大幅な成長が見込まれています。

目次

第1章 調査手法と範囲

• 調査手法
• 調査の仮定
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 腎機能検査市場に関する研究のサンプルサイズ：
    • 一次情報：
    • 1次調査の詳細
    • セカンダリデータソース：
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• 市場モデル
• 目的

第2章 エグゼクティブサマリー

• 市場のスナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系列の見通し
  • 親市場の見通し
  • 関連/補助的な市場の見通し
• 2022年の製品の浸透と成長の見通しマッピング（100万米ドル）
• 事業環境分析
  • SWOT分析;要因別（政治と法律、経済と技術）
  • ポーターのファイブフォース分析
• COVID-19影響分析：
  • Esrd、Aki、Eskd、Ckd、およびその他の腎障害に苦しむ患者への影響
• 市場力学
  • 市場促進要因分析
    • 革新的な腎機能検査のイントロダクション
    • 研究開発への投資の増加
    • 急性腎障害および関連する慢性腎疾患の有病率の増加
  • 市場抑制要因分析
    • 腎臓病に対する意識の低さ
  • 市場課題分析
    • 腎機能検査に関連する制限

第4章 製品ビジネス分析

• 腎機能検査市場：製品変動分析
• クリアランス試験
• 血液検査
• 尿検査
• 希釈および濃度試験
• その他のテスト

第5章 最終用途のビジネス分析

• 腎機能検査市場：エンドユーザーの変動分析
• 病院
• 診断検査室
• 調査および研究所
• その他

第6章 腎機能検査市場：製品および最終用途別の地域推定・動向分析

• 北米
  • SWOT分析：
  • 米国
    • 主要な国のダイナミクス
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • カナダ
    • 主要な国のダイナミクス
    • 競合シナリオ
    • 規制の枠組み
    • 病気の有病率
• 欧州
  • SWOT分析：
  • ドイツ
    • 主要な国のダイナミクス
    • 病気の有病率
    • 規制の枠組み
  • 英国
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • フランス
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • イタリア
    • 主要な国のダイナミクス
    • 規制の枠組み
  • スペイン
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • デンマーク
    • 規制の枠組み
    • 病気の有病率
  • スウェーデン
    • 規制の枠組み
    • 病気の有病率
  • ノルウェー
    • 病気の有病率
  • ロシア
    • 病気の有病率
• アジア太平洋地域
  • SWOT分析：
  • 日本
    • 規制の枠組み
    • 病気の有病率
  • 中国
    • 規制の枠組み
    • 病気の有病率
  • インド
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • 韓国
    • 規制の枠組み
    • 病気の有病率
  • オーストラリア
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • タイ
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 病気の有病率
  • シンガポール
    • 規制の枠組み
    • 病気の有病率
• ラテンアメリカ
  • SWOT分析：
  • ブラジル
    • 規制の枠組み
    • 病気の有病率
  • メキシコ
    • 規制の枠組み
    • 病気の有病率
  • アルゼンチン
    • 規制の枠組み
    • 病気の有病率
• 中東とアフリカ
  • SWOT分析：
  • 南アフリカ
    • 規制の枠組み
    • 病気の有病率
  • UEA
    • 規制の枠組み
    • 病気の有病率
  • サウジアラビア
    • 規制の枠組み
    • 病気の有病率
  • クウェート
    • 規制の枠組み
    • 病気の有病率

第7章 競合情勢

• 市場参入企業の概要
  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Siemens Healthineers
  • Randox Laboratories Ltd
  • Quest Diagnostics
  • Acon Laboratories, Inc.
  • Nova Biomedical Corporation
  • Laboratory Corporation Of America Holdings
• 財務実績
• 市場参入企業の分類
  • 市場のリーダー
    • 戦略マッピング腎機能検査の市場シェア分析、2022年
  • 戦略マッピング
    • 拡張
    • コラボレーション
    • 製品の発売
    • パートナーシップ

List of Tables

• Table 1. Premarket approval process
• Table 2. Key companies adopting expansion strategy
• Table 3. Key companies adopting collaboration strategy
• Table 4. Key companies launching new products/services
• Table 5. Key companies adopting partnership strategy
• Table 6. List of Secondary Sources
• Table 7. List of Abbreviations
• Table 8. Global Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 9. Global Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 10. Global Kidney Function Tests Market, by Region, 2018 - 2030 (USD Million)
• Table 11. North America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
• Table 12. North America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 13. North America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 14. U.S. Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 15. U.S. Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 16. Canada Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 17. Canada Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 18. Europe Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
• Table 19. Europe Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 20. Europe Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 21. Germany Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 22. Germany Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 23. UK Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 24. UK Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 25. France Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 26. France Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 27. Italy Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 28. Italy Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 29. Spain Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 30. Spain Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 31. Denmark Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 32. Denmark Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 33. Sweden Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 34. Sweden Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 35. Norway Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 36. Norway Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 37. Russia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 38. Russia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 39. Asia Pacific Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
• Table 40. Asia Pacific Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 41. Asia Pacific Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 42. Japan Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 43. Japan Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 44. China Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 45. China Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 46. India Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 47. India Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 48. South Korea Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 49. South Korea Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 50. Australia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 51. Australia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 52. Singapore Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 53. Singapore Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 54. Thailand Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 55. Thailand Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 56. Latin America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
• Table 57. Latin America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 58. Latin America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 59. Brazil Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 60. Brazil Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 61. Mexico Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 62. Mexico Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 63. Argentina Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 64. Argentina Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 65. Middle East & Africa Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
• Table 66. Middle East & Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 67. Middle East & Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 68. South Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 69. South Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 70. Saudi Arabia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 71. Saudi Arabia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 72. UAE Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 73. UAE Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
• Table 74. Kuwait Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
• Table 75. Kuwait Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Executives contacted
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Kidney function tests market estimation process
• Fig. 10 Market snapshot
• Fig. 11 Market segmentation and scope
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 14 Porter's five forces analysis
• Fig. 15 Market driver impact
• Fig. 16 Reported causes of end-stage renal disease in the U.S.
• Fig. 17 Percentage of U.S. adults aged 18 or older with CKD
• Fig. 18 Market restraint relevance analysis (Current & future impact)
• Fig. 19 Kidney function test market: product outlook and key takeaways
• Fig. 20 Kidney function tests market: product movement analysis
• Fig. 21 Clearance tests market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Blood tests market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Urine tests market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Dilution & concentration tests market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Other tests market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Kidney function test market: end-use outlook and key takeaways
• Fig. 27 Kidney function test market: end-user movement analysis
• Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Regional marketplace: key takeaways
• Fig. 33 Regional marketplace: key takeaways
• Fig. 34 North America: SWOT analysis
• Fig. 35 North America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Key country dynamics
• Fig. 37 U.S. kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 Canada kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe: SWOT analysis
• Fig. 41 Europe kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 Germany kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Key country dynamics
• Fig. 46 UK kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Key country dynamics
• Fig. 49 France kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Regulatory framework
• Fig. 52 Italy kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Regulatory framework
• Fig. 55 Spain kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Denmark kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Sweden kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Norway kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Russia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Asia Pacific: SWOT analysis
• Fig. 61 Asia Pacific kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Japan kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 China kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 India kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 South Korea kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Regulatory framework
• Fig. 69 Australia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Regulatory framework
• Fig. 72 Thailand kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Singapore kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Latin America: SWOT analysis
• Fig. 75 Latin America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Brazil kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Mexico kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Argentina kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Middle East and Africa: SWOT analysis
• Fig. 80 Middle East and Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 South Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 UAE kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Saudi Arabia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Kuwait kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Market participant categorization
• Fig. 86 Kidney function tests market share analysis, 2022
• Fig. 87 Strategic framework

Kidney Function Tests Market Growth & Trends:

The global kidney function tests market size is expected to reach USD 1.39 billion by 2030, registering at a CAGR of 6.50% from 2023 to 2030, according to a new report by Grand View Research, Inc. Key factors such as high prevalence of kidney diseases, the rising R&D activities, increasing investments by market players, and technological innovations are anticipated to significantly drive the market growth. Moreover, the growing number of initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests is a major factor likely to boost the market.

Introduction of innovative kidney function tests in the market by the operating players is increasing the adoption of these diagnostics tests. For instance, in December 2022, Journey Biosciences, Inc. launched its leading product-NaviDKD. It is a biomarker-based blood test, which evaluates the peril of renal disease in people with diabetes years before the symptoms appear. Along with its patented compass reporting platform, the product provides actionable insights for managing and preventing complications before they arise. Such developments are foreseen to fuel the market during the forecast period.

Furthermore, rising R&D initiatives for the development of novel products are expected to significantly fuel the market growth during the forecast period. For instance, in February 2021, Researchers from the University Hospitals of Derby and Burton, NHS Foundation Trust, and the University of Nottingham received USD 2.32 million in funding to help improve the treatment and diagnosis of renal diseases. Researchers will use multi-parametric MRI scanning to evaluate patients suffering from CKD. Similarly, the Canadian kidney research organization received a new USD 11.8 million investment to support its work through 2027. The Can-SOLVE Chronic Kidney Disease Network is the largest-ever kidney research initiative in Canada.

The COVID-19 pandemic has been associated with increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor and availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to temporary closure of other medical services. The diagnosis of several renal diseases deferred during the pandemic due to suspension of non-urgent visits and testing services.

Moreover, the growing prevalence of renal diseases is projected to increase the demand for diagnostic tests during the study period. For instance, according to The National Kidney Foundation, Inc., an estimated 37 million people in the U.S., i.e., more than one in seven adults, are living with some form of renal disease. Similarly, according to data published by FDA, about 10,000 children in the U.S. develop acute kidney infections (AKI) every year. These children possess a survival rate of around 38%-43%. The mortality rate for neonates with AKI is around 60%. Such factors are likely to drive the demand for neonatal hemodialysis, thereby driving the market growth.

On the other hand, low awareness regarding renal diseases is expected to hamper the market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease and about 90% remain unaware of the condition. Major risk factors for the disease are high blood pressure and diabetes as well as heart disease, obesity, & family history of kidney disease. However, various government bodies are initiating programs for raising awareness of kidney function tests. For instance, Tamilnadu Kidney Research Foundation has conducted 1,279 awareness programs until March 2020.

Kidney Function Tests Market Report Highlights:

• By product, the clearance tests segment held the largest share of the market. These tests ensure that there is minimal variation in performance owing to their optimum sensitivity and precision. The low cost and easy availability of these products in the market lead to their increased adoption.

• By end-user, the hospitals segment accounted for the dominant market share in 2022, due to the rising demand for IVD tests because of increase in the prevalence of CKD.

• North America dominated the global market in 2022 due to the well-established healthcare infrastructure, favorable reimbursement policies and government initiatives in the region.

• Asia Pacific is expected to grow considerably in the future owing to the increasing awareness programs about CKD in emerging economies, such as China & India.

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Research Methodology
• 1.2 Research Assumptions
  • 1.2.1 Estimates And Forecast Timeline
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Sample Size For The Study On Kidney Function Tests Market:
    • 1.3.5.1 Primary Sources:
    • 1.3.5.2 Details Of Primary Research
    • 1.3.5.3 Secondary Data Sources:
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Market Model
• 1.7 Objectives
  • 1.7.1 Objective 1:
  • 1.7.2 Objective 2:

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, And Scope

• 3.1 Market Segmentation And Scope
• 3.2 Market Lineage Outlook
  • 3.2.1 Parent Market Outlook
  • 3.2.2 Related/Ancillary Market Outlook
• 3.3 Penetration And Growth Prospect Mapping For Product, 2022 (USD Million)
• 3.4 Business Environment Analysis
  • 3.4.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2 Porter's Five Forces Analysis
• 3.5 Covid-19 Impact Analysis:
  • 3.5.1 Impact On Patients Suffering From Esrd, Aki, Eskd, Ckd, And Other Kidney Disorders
• 3.6 Market Dynamics
  • 3.6.1 Market Driver Analysis
    • 3.6.1.1 Introduction Of Innovative Kidney Function Tests
    • 3.6.1.3 Increasing Investments In R&D
    • 3.6.1.4 Increasing Prevalence Of Acute Kidney Injury And Associated Chronic Kidney Disease
  • 3.6.2 Market Restraint Analysis
    • 3.6.2.1 Low Awareness Regarding Kidney Diseases
  • 3.6.3 Market Challenge Analysis
    • 3.6.3.1 Limitations Associated With Kidney Function Tests

Chapter 4 Product Business Analysis

• 4.1 Kidney Function Tests Market: Product Movement Analysis
• 4.2 Clearance Tests
  • 4.2.1 Clearance Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.3 Blood Tests
  • 4.3.1 Blood Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.4 Urine Tests
  • 4.4.1 Urine Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.5 Dilution & Concentration Tests
  • 4.5.1 Dilution & Concentration Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.6 Other Tests
  • 4.6.1 Other Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 End-Use Business Analysis

• 5.1 Kidney Function Tests Market: End-User Movement Analysis
• 5.2 Hospitals
  • 5.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.3 Diagnostic Laboratories
  • 5.3.1 Diagnostic Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.4 Research Laboratories And Institutes
  • 5.4.1 Research Laboratories And Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.5 Others
  • 5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Kidney Function Tests Market: Regional Estimates And Trend Analysis, By Product & End-Use

• 6.1 North America
  • 6.1.1 Swot Analysis:
    • 6.1.1.1 North America Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.1.2 U.S.
    • 6.1.2.1 Key Country Dynamics
    • 6.1.2.2 Competitive Scenario
    • 6.1.2.3 Regulatory Framework
    • 6.1.2.4 Reimbursement Scenario
    • 6.1.2.5 U.S. Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.1.3 Canada
    • 6.1.3.1 Key Country Dynamics
    • 6.1.3.2 Competitive Scenario
    • 6.1.3.3 Regulatory Framework
    • 6.1.3.4 Disease Prevalence
    • 6.1.3.5 Canada Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.2 Europe
  • 6.2.1 Swot Analysis:
    • 6.2.1.1 Europe Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2 Germany
    • 6.2.2.1 Key Country Dynamics
    • 6.2.2.2 Disease Prevalence
    • 6.2.2.3 Regulatory Framework
    • 6.2.2.5 Germany Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3 Uk
    • 6.2.3.1 Key Country Dynamics
    • 6.2.3.2 Regulatory Framework
    • 6.2.3.3 Disease Prevalence
    • 6.2.3.5 Uk Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4 France
    • 6.2.4.1 Key Country Dynamics
    • 6.2.4.2 Regulatory Framework
    • 6.2.4.3 Disease Prevalence
    • 6.2.4.5 France Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.5 Italy
    • 6.2.5.1 Key Country Dynamics
    • 6.2.5.2 Regulatory Framework
    • 6.2.5.4 Italy Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.6 Spain
    • 6.2.6.1 Key Country Dynamics
    • 6.2.6.2 Regulatory Framework
    • 6.2.6.1 Disease Prevalence
    • 6.2.6.3 Spain Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.7 Denmark
    • 6.2.7.1 Regulatory Framework
    • 6.2.6.2 Disease Prevalence
    • 6.2.7.4 Denmark Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.8 Sweden
    • 6.2.8.1 Regulatory Framework
    • 6.2.8.2 Disease Prevalence
    • 6.2.8.4 Sweden Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.9 Norway
    • 6.2.9.1 Disease Prevalence
    • 6.2.9.3 Norway Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.10 Russia
    • 6.2.10.1 Disease Prevalence
    • 6.2.10.3 Russia Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3 Asia Pacific
  • 6.3.1 Swot Analysis:
    • 6.3.1.1 Asia Pacific Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2 Japan
    • 6.3.2.1 Regulatory Framework
    • 6.3.2.2 Disease Prevelance
    • 6.3.2.3 Japan Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3 China
    • 6.3.3.1 Regulatory Framework
    • 6.3.3.2 Disease Prevalance
    • 6.3.3.3 China Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4 India
    • 6.3.4.1 Key Country Dynamics
    • 6.3.4.2 Regulatory Framework
    • 6.3.4.3 Disease Prevalence
    • 6.3.4.4 India Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5 South Korea
    • 6.3.5.1 Regulatory Framework
    • 6.3.5.2 Disease Prevalence
    • 6.3.5.3 South Korea Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6 Australia
    • 6.3.6.1 Key Country Dynamics
    • 6.3.6.2 Regulatory Framework
    • 6.3.6.3 Disease Prevalance
    • 6.3.6.5 Australia Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7 Thailand
    • 6.3.7.1 Key Country Dynamics
    • 6.3.7.2 Regulatory Framework
    • 6.3.7.3 Disease Prevalence
    • 6.3.7.5 Thailand Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8 Singapore
    • 6.3.8.1 Regulatory Framework
    • 6.3.8.2 Disease Prevalence
    • 6.3.8.4 Singapore Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4 Latin America
  • 6.4.1 Swot Analysis:
    • 6.4.1.1 Latin America Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2 Brazil
    • 6.4.2.1 Regulatory Framework
    • 6.4.2.2 Disease Prevalance
    • 6.4.2.3 Brazil Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3 Mexico
    • 6.4.3.1 Regulatory Framework
    • 6.4.3.2 Disease Prevalence
    • 6.4.3.4 Mexico Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4 Argentina
    • 6.4.4.1 Regulatory Framework
    • 6.4.4.2 Disease Prevalance
    • 6.4.4.4 Argentina Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5 Middle East And Africa
  • 6.5.1 Swot Analysis:
    • 6.5.1.1 Middle East And Africa Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2 South Africa
    • 6.5.2.1 Regulatory Framework
    • 6.5.2.2 Disease Prevalence
    • 6.5.2.3 South Africa Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3 UEA
    • 6.5.3.1 Regulatory Framework
    • 6.5.3.2 Disease Prevalance
    • 6.5.3.3 Uae Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4 Saudi Arabia
    • 6.5.4.1 Regulatory Framework
    • 6.5.4.2 Disease Prevalence
    • 6.5.4.3 Saudi Arabia Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5 Kuwait
    • 6.5.5.1 Regulatory Framework
    • 6.5.5.2 Disease Prevalence
    • 6.5.5.3 Kuwait Kidney Function Tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

• 7.1 Participant's Overview
  • 7.1.1 Abbott
  • 7.1.2 Danaher
  • 7.1.3 F. Hoffmann-La Roche Ltd.
  • 7.1.4 Sysmex Corporation
  • 7.1.5 Siemens Healthineers
  • 7.1.6 Randox Laboratories Ltd
  • 7.1.7 Quest Diagnostics
  • 7.1.8 Acon Laboratories, Inc.
  • 7.1.9 Nova Biomedical Corporation
  • 7.1.10 Laboratory Corporation Of America Holdings
• 7.2 Financial Performance
• 7.3 Participant Categorization
  • 7.3.1 Market Leaders
    • 7.3.1.1 Strategy Mapping Kidney Function Tests Market Share Analysis, 2022
  • 7.3.3 Strategy Mapping
    • 7.3.3.1 Expansion
    • 7.3.3.2 Collaboration
    • 7.3.3.3 Product Launch
    • 7.3.3.4 Partnership